Head-to-head · Cost-Efficiency Index
Found vs HealthRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Found
Insured shoppers willing to prepay 12 months upfront to reach the lowest advertised rate, who also want behavior-change coaching bundled in.
Visit FoundHealthRX
Shoppers who want the whole term ladder published before intake and are reading it carefully enough to spot which rung the headline came from.
Visit HealthRXThe verdict
Found takes it, leading the Cost-Efficiency Index 88 to 74. A real insurance-billing pathway on both molecules — but the widely-quoted $99/mo headline requires an insurance plan AND a full year prepaid upfront; the true no-commitment rate is $199-289/mo. HealthRX still earns a C — Shoppers who want the whole term ladder published before intake and are reading it carefully enough to spot which rung the headline came from.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Found.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Found | HealthRX |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 74/100 |
| Semaglutide / mo | $199/mo (insurance-linked) | $190/mo (all doses, compounded) |
| Tirzepatide / mo | $199/mo (insurance-linked) | $239/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,280 |
| Tirzepatide / yr (modeled) | $2,388 | $2,868 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #7 | #38 |
Found
88/100Where the value is
- Genuine insurance-billing pathway, unlike most cash-only compounded competitors — most members reportedly pay under $30/visit
- Nationwide
- Strong behavior-change program adds value
The tradeoffs
- The advertised '$99/mo' headline requires BOTH an insurance-linked plan AND a 12-month prepay at once — the real month-to-month rate is $199/mo (insured) or $289/mo (cash-pay), 2-3x the headline
- Coaching subscription can't be unbundled, which reduces contract flexibility
HealthRX
74/100Where the value is
- All 50 states, printed in the site's own header strip rather than left to the intake quiz
- Specific, checkable LegitScript certificate number (50087439) rather than just a generic badge image
- "Same price at every dose" policy avoids dose-based price creep
The tradeoffs
- The advertised $99 and $179 are twelve-month prepay rungs — $1,188 and $2,148 up front. The standing month-to-month rates are $190 and $239, roughly double and a third higher
- A second discount is stacked on the same headline: $99 semaglutide and $149 tirzepatide are also first-month intro rates on the monthly plan, so month two costs more than month one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.